Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs Cincinnati Financial Corporation (CINF) Price & Performance

ARK Genomic Revolution ETF
Cincinnati Financial Corporation

Price performance

Price movement over the last 24 hours

Key statistics

ARK Genomic Revolution ETF vs Cincinnati Financial Corporation — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Cincinnati Financial Corporation trades at $180.5 (market cap $27.73B). The key difference: Cincinnati Financial Corporation pays a 2.1% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Cincinnati Financial Corporation nearer its low. Which is the better fit depends on your goals.

ARKGCINF
Sector
Sector/ThematicFinancials
52-Week High
$43.57$192.03
52-Week Low
$23.09$145.80
Market Cap
$27.73B
Enterprise Value
$27.41B
Dividend Yield
2.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.

The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.

Cincinnati Financial Corporation

CINF trades at $179.28, up 2.19% today, near its consensus price target of $185.75. The stock shows strong fundamentals with a P/E of 10.25, net income margin of 21.33%, and consistent earnings beats in recent quarters. Technical indicators are bearish overall, with the current price near the pivot point of $178. Recent news highlights a scheduled Q2 2026 earnings webcast and a 65-year dividend streak, with a $0.94 dividend paid in July 2026.

Outlook remains positive due to valuation appeal and earnings momentum, but risks include technical bearish signals and exposure to catastrophe losses. Revenue growth is steady, projected to reach $12.9B in 2026, supporting a bullish analyst consensus despite mixed technicals.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Read more on CINF